Cargando…
Early TP53 Alterations Shape Gastric and Esophageal Cancer Development
SIMPLE SUMMARY: Recent evidence establishes that gastric and esophageal (GE) adenocarcinomas are similar cancers at cellular, genomic, and epigenomic levels. Human GE adenocarcinomas develop TP53 mutations at early stages of malignant progression. This contrasts with other gastrointestinal adenocarc...
Autores principales: | Sahgal, Pranshu, Huffman, Brandon M., Patil, Deepa T., Chatila, Walid K., Yaeger, Rona, Cleary, James M., Sethi, Nilay S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657039/ https://www.ncbi.nlm.nih.gov/pubmed/34885025 http://dx.doi.org/10.3390/cancers13235915 |
Ejemplares similares
-
Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitors
por: Sahgal, Pranshu, et al.
Publicado: (2023) -
Alterations of the TP53 Gene in Gastric and Esophageal Carcinogenesis
por: Bellini, Marilanda Ferreira, et al.
Publicado: (2012) -
Early TP53 Alterations Engage Environmental Exposures to Promote Gastric Premalignancy in an Integrative Mouse Model
por: Sethi, Nilay S., et al.
Publicado: (2020) -
Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors
por: Sahgal, Pranshu, et al.
Publicado: (2023) -
TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19
por: Harford, Joe B., et al.
Publicado: (2022)